Dr Michael Gregory Voss, MD | |
9200 W Wisconsin Ave, Milwaukee, WI 53226-3522 | |
(414) 805-6550 | |
(414) 805-6565 |
Full Name | Dr Michael Gregory Voss |
---|---|
Gender | Male |
Speciality | Endocrinology |
Experience | 7 Years |
Location | 9200 W Wisconsin Ave, Milwaukee, Wisconsin |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1457881864 | NPI | - | NPPES |
1033471909 | Medicaid | WI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 7281920 (Wisconsin) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Froedtert Memorial Lutheran Hospital | Milwaukee, WI | Hospital |
St Josephs Community Hospital West Bend | West bend, WI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
The Medical College Of Wisconsin Inc | 2668384371 | 1813 |
Froedtert Andthe Medical College Of Wisconsin Community Physicians Inc | 3678760063 | 1040 |
News Archive
Millennium: The Takeda Oncology Company today reported on data from oral presentations of VELCADE® (bortezomib) for Injection based therapy in multiple myeloma presented at the 2010 Annual Meeting of the American Society of Clinical Oncology (ASCO). These data highlight VELCADE based therapy in both transplant and non-transplant eligible previously untreated multiple myeloma patients, as well as VELCADE used as induction and/or maintenance therapy.
More than half of all air passengers experience significant blood oxygen decreases at high altitudes, UK researchers report in the scientific journal Anaesthesia. We take a look at the findings and EU research in the aeronautics field.
CVS Caremark said the company's comprehensive adherence program for people with diabetes positively impacts medication adherence for both new and continuing patients. A review of data tracking the program found that 75.6 percent of patients continuing on a diabetes therapy who participated in the adherence program maintained optimal adherence to their prescribed therapy vs. 61.2 percent in the control group.
Medicaid is bureaucratic and costly, and the stimulus and new federal health care law have made a bad problem even worse, shackling states with unrealistic mandates.
› Verified 1 days ago
Entity Name | The Medical College Of Wisconsin Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1699720086 PECOS PAC ID: 2668384371 Enrollment ID: O20031120000259 |
News Archive
Millennium: The Takeda Oncology Company today reported on data from oral presentations of VELCADE® (bortezomib) for Injection based therapy in multiple myeloma presented at the 2010 Annual Meeting of the American Society of Clinical Oncology (ASCO). These data highlight VELCADE based therapy in both transplant and non-transplant eligible previously untreated multiple myeloma patients, as well as VELCADE used as induction and/or maintenance therapy.
More than half of all air passengers experience significant blood oxygen decreases at high altitudes, UK researchers report in the scientific journal Anaesthesia. We take a look at the findings and EU research in the aeronautics field.
CVS Caremark said the company's comprehensive adherence program for people with diabetes positively impacts medication adherence for both new and continuing patients. A review of data tracking the program found that 75.6 percent of patients continuing on a diabetes therapy who participated in the adherence program maintained optimal adherence to their prescribed therapy vs. 61.2 percent in the control group.
Medicaid is bureaucratic and costly, and the stimulus and new federal health care law have made a bad problem even worse, shackling states with unrealistic mandates.
› Verified 1 days ago
Entity Name | Froedtert &the Medical College Of Wisconsin Community Physicians Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1568787448 PECOS PAC ID: 3678760063 Enrollment ID: O20101210000699 |
News Archive
Millennium: The Takeda Oncology Company today reported on data from oral presentations of VELCADE® (bortezomib) for Injection based therapy in multiple myeloma presented at the 2010 Annual Meeting of the American Society of Clinical Oncology (ASCO). These data highlight VELCADE based therapy in both transplant and non-transplant eligible previously untreated multiple myeloma patients, as well as VELCADE used as induction and/or maintenance therapy.
More than half of all air passengers experience significant blood oxygen decreases at high altitudes, UK researchers report in the scientific journal Anaesthesia. We take a look at the findings and EU research in the aeronautics field.
CVS Caremark said the company's comprehensive adherence program for people with diabetes positively impacts medication adherence for both new and continuing patients. A review of data tracking the program found that 75.6 percent of patients continuing on a diabetes therapy who participated in the adherence program maintained optimal adherence to their prescribed therapy vs. 61.2 percent in the control group.
Medicaid is bureaucratic and costly, and the stimulus and new federal health care law have made a bad problem even worse, shackling states with unrealistic mandates.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Michael Gregory Voss, MD 9200 W Wisconsin Ave, Milwaukee, WI 53226-3522 Ph: (414) 805-6550 | Dr Michael Gregory Voss, MD 9200 W Wisconsin Ave, Milwaukee, WI 53226-3522 Ph: (414) 805-6550 |
News Archive
Millennium: The Takeda Oncology Company today reported on data from oral presentations of VELCADE® (bortezomib) for Injection based therapy in multiple myeloma presented at the 2010 Annual Meeting of the American Society of Clinical Oncology (ASCO). These data highlight VELCADE based therapy in both transplant and non-transplant eligible previously untreated multiple myeloma patients, as well as VELCADE used as induction and/or maintenance therapy.
More than half of all air passengers experience significant blood oxygen decreases at high altitudes, UK researchers report in the scientific journal Anaesthesia. We take a look at the findings and EU research in the aeronautics field.
CVS Caremark said the company's comprehensive adherence program for people with diabetes positively impacts medication adherence for both new and continuing patients. A review of data tracking the program found that 75.6 percent of patients continuing on a diabetes therapy who participated in the adherence program maintained optimal adherence to their prescribed therapy vs. 61.2 percent in the control group.
Medicaid is bureaucratic and costly, and the stimulus and new federal health care law have made a bad problem even worse, shackling states with unrealistic mandates.
› Verified 1 days ago
Julia Bonner, M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 3351 North Downer Avenue, Milwaukee, WI 53211 Phone: 414-229-5684 | |
Dr. Zachary Smith, DO Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-955-6830 Fax: 414-955-6214 | |
Dr. Christopher Patrick Boyd, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-6000 Fax: 414-805-6280 | |
Umair Bajwa, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-0812 Fax: 414-805-0855 | |
Rasika Surajyam Chepuri, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-955-7040 Fax: 414-955-6211 | |
Soryal A Soryal, M.D Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1020 N 12th St, 3rd Floor, Milwaukee, WI 53233 Phone: 414-219-7300 | |
Aboud Affi, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1218 W Kilbourn Ave, Suite 404, Milwaukee, WI 53233 Phone: 414-291-3100 |